230 related articles for article (PubMed ID: 33091144)
1. Palatine Tonsils Primary Presentation of Blastoid Variant of Mantle Cell Lymphoma: Case Report.
Marques JAS; Ferreira F; Melo DP; Santos M; Vaz RP
Head Neck Pathol; 2021 Jun; 15(2):588-592. PubMed ID: 33091144
[TBL] [Abstract][Full Text] [Related]
2. Blastoid variant of mantle cell lymphoma in palatine tonsil.
Valente VB; de Castro TF; Takamiya AS; Callestini R; Xavier-Junior JCC; Cortopassi GM; Neto SC; Collado FU; Biasoli ÉR; Miyahara GI; Bernabé DG
Oral Oncol; 2021 Nov; 122():105552. PubMed ID: 34610523
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic characteristics and prognositic indicators of tonsillar mantle cell lymphoma].
Hou WH; Wei P; Xie JL; Zheng YY; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):158-162. PubMed ID: 29534352
[No Abstract] [Full Text] [Related]
4. Non-Hodgkin's lymphoma of Waldeyer's ring.
Albada J; Hordijk GJ; van Unnik JA; Dekker AW
Cancer; 1985 Dec; 56(12):2911-3. PubMed ID: 3840405
[TBL] [Abstract][Full Text] [Related]
5. Bendamustine-rituximab in mantle cell lymphoma.
Lipsky A; Martin P
Lancet Haematol; 2017 Jan; 4(1):e2-e3. PubMed ID: 27927585
[No Abstract] [Full Text] [Related]
6. Clinical manifestations in children with tonsillar lymphoma: A systematic review.
Guimarães AC; de Carvalho GM; Bento LR; Correa C; Gusmão RJ
Crit Rev Oncol Hematol; 2014 May; 90(2):146-51. PubMed ID: 24387945
[TBL] [Abstract][Full Text] [Related]
7. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
[TBL] [Abstract][Full Text] [Related]
8. What lies beneath: Cutaneous involvement of mantle cell lymphoma underlying an insect-bite-like reaction.
Shah RA; Powell PR; Parekh PK
J Cutan Pathol; 2021 Apr; 48(4):563-566. PubMed ID: 32776338
[TBL] [Abstract][Full Text] [Related]
9. Blastoid mantle cell lymphoma presenting as acute leukemia: a case report.
Dongre A; Kanchankar N; Deshmukh M; Wasnik D; Dongre T
Pan Afr Med J; 2021; 39():150. PubMed ID: 34527166
[TBL] [Abstract][Full Text] [Related]
10. [Palatine tonsil lymphoma in children with tonsillar asymmetry. Case report].
Cuestas G; Martínez Font A; Demarchi MV; Martínez Corvalán MP; García Rivello H; Morandi A; Razetti J; Boccio C
Arch Argent Pediatr; 2015 Aug; 113(4):e219-22. PubMed ID: 26172022
[TBL] [Abstract][Full Text] [Related]
11. Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma.
Villa D; Sehn LH; Savage KJ; Toze CL; Song K; den Brok WD; Freeman CL; Scott DW; Gerrie AS
Blood Adv; 2020 Aug; 4(15):3486-3494. PubMed ID: 32735654
[TBL] [Abstract][Full Text] [Related]
12. Association between unilateral tonsillar enlargement and lymphoma in children: A systematic review and meta-analysis.
Guimarães AC; de Carvalho GM; Correa CR; Gusmão RJ
Crit Rev Oncol Hematol; 2015 Mar; 93(3):304-11. PubMed ID: 25487766
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma involving tonsils: a clinicopathologic study of 83 cases.
Tashakori M; Kim DH; Kanagal-Shamanna R; Vega F; Miranda RN; Jain P; Wang M; Medeiros LJ; Ok CY
Hum Pathol; 2021 Dec; 118():60-68. PubMed ID: 34655612
[TBL] [Abstract][Full Text] [Related]
14. Blastoid variant of mantle cell lymphoma with lactic acidosis: a case report.
Ohtsubo K; Imamura R; Seki R; Ohshima K; Hashiguchi M; Yakushiji K; Yoshimoto K; Ogata H; Okamura T; Sata M
Int J Hematol; 2004 Dec; 80(5):428-31. PubMed ID: 15646654
[TBL] [Abstract][Full Text] [Related]
15. High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas. A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG).
Weide R; Hess G; Köppler H; Heymanns J; Thomalla J; Aldaoud A; Losem C; Schmitz S; Haak U; Huber C; Unterhalt M; Hiddemann W; Dreyling M;
Leuk Lymphoma; 2007 Jul; 48(7):1299-306. PubMed ID: 17613757
[TBL] [Abstract][Full Text] [Related]
16. What is the optimal initial management of the older MCL patient?
Kluin-Nelemans JC; Doorduijn JK
Best Pract Res Clin Haematol; 2018 Mar; 31(1):99-104. PubMed ID: 29452672
[TBL] [Abstract][Full Text] [Related]
17. Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma.
Albertsson-Lindblad A; Kolstad A; Laurell A; Räty R; Grønbæk K; Sundberg J; Pedersen LB; Ralfkiær E; Karjalainen-Lindsberg ML; Sundström C; Ehinger M; Geisler C; Jerkeman M
Blood; 2016 Oct; 128(14):1814-1820. PubMed ID: 27354719
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab.
Ramsower CA; Rosenthal A; Robetorye RS; Mwangi R; Maurer M; Villa D; McDonnell T; Feldman A; Cohen JB; Habermann T; Campo E; Clot G; Bühler MM; Kulis M; Martin-Subero JI; Giné E; Cook JR; Hill B; Raess PW; Beiske KH; Reichart A; Hartmann S; Holte H; Scott D; Rimsza L
Br J Haematol; 2024 Jan; 204(1):160-170. PubMed ID: 37881141
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin lymphoma presenting as bilateral tonsillar hypertrophy: case report.
Khan SU; Kenefick C; O'Leary G; Lucey JJ
Ear Nose Throat J; 2010 Apr; 89(4):E4-5. PubMed ID: 20397136
[TBL] [Abstract][Full Text] [Related]
20. Secondary malignancies among mantle cell lymphoma patients.
Abalo KD; Smedby KE; Ekberg S; Eloranta S; Pahnke S; Albertsson-Lindblad A; Jerkeman M; Glimelius I
Eur J Cancer; 2023 Dec; 195():113403. PubMed ID: 37952281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
